TY - JOUR
T1 - NCCN Guidelines® Insights
T2 - Head and Neck Cancers, Version 2.2025
AU - Colevas, A. Dimitrios
AU - Cmelak, Anthony J.
AU - Pfister, David G.
AU - Spencer, Sharon
AU - Adkins, Douglas
AU - Birkeland, Andrew C.
AU - Brizel, David M.
AU - Busse, Paul M.
AU - Caudell, Jimmy J.
AU - Durm, Greg
AU - Fakhry, Carole
AU - Galloway, Thomas
AU - Geiger, Jessica L.
AU - Gillison, Maura L.
AU - Glastonbury, Christine
AU - Haddad, Robert I.
AU - Hicks, Wesley L.
AU - Hitchcock, Ying J.
AU - Jimeno, Antonio
AU - Juloori, Aditya
AU - Kase, Michael
AU - Leizman, Debra
AU - Maghami, Ellie
AU - Mell, Loren K.
AU - Mittal, Bharat B.
AU - Pinto, Harlan A.
AU - Price, Katharine
AU - Rocco, James W.
AU - Rodriguez, Cristina P.
AU - Schwartz, David
AU - Shah, Jatin P.
AU - Sher, David
AU - John, Maie St
AU - Wang, He
AU - Weinstein, Gregory
AU - Worden, Francis
AU - Bruce, Justine Yang
AU - Yom, Sue S.
AU - Zhen, Weining
AU - Montgomery, Sarah
AU - Darlow, Susan D.
N1 - Publisher Copyright:
© JNCCN—Journal of the National Comprehensive Cancer Network.
PY - 2025/2
Y1 - 2025/2
N2 - The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses, as well as occult primary cancer, salivary gland cancer, and mucosal melanoma (MM). The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of nasopharynx cancer and ongoing research in this area.
AB - The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses, as well as occult primary cancer, salivary gland cancer, and mucosal melanoma (MM). The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of nasopharynx cancer and ongoing research in this area.
KW - Education, Medical, Continuing
KW - Head and Neck Neoplasms/therapy
KW - Humans
KW - Practice Guidelines as Topic
UR - https://www.scopus.com/pages/publications/85217976760
U2 - 10.6004/jnccn.2025.0007
DO - 10.6004/jnccn.2025.0007
M3 - Article
C2 - 39938471
AN - SCOPUS:85217976760
SN - 1540-1405
VL - 23
SP - 2
EP - 11
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 2
ER -
